Immunocore competitorsClear all

Immunocore's top competitors include LogicBio Therapeutics, F-star Biotechnology, KemPharm and Juno Therapeutics.
Immunocore
Immunocore
A world-leading biotechnology company with a highly innovative immune-oncology T cell receptor platform technology
LogicBio Therapeutics
LogicBio Therapeutics
LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
F-star Biotechnology
F-star Biotechnology
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
KemPharm
KemPharm
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
Juno Therapeutics
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
Founding Date
Founding Date
N/A
Founding Date
2014
Founding Date
2006
Founding Date
2006
Founding Date
2013
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Milton, GB HQ
Conshohocken, US
Rockville, US
Locations
Lexington, US HQ
Locations
Cambridge, GB HQ
Wien, AT
Cambridge, US
Locations
Kissimmee, US HQ
Blacksburg, US
Coralville, US
Coralville, US
Locations
Seattle, US HQ
Göttingen, DE
München, DE
München, DE
Bothell, US
Brisbane, US
Employees
Employees
3141% decrease
Employees
4178% increase
Employees
864% decrease
Employees
333% increase
Employees
7152% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
129.4 m
Valuation ($)
N/A
Valuation ($)
51.4 m
Valuation ($)
N/A
Twitter followers
Twitter followers
2.3 k
Twitter followers
361
Twitter followers
1.2 k
Twitter followers
144
Twitter followers
2.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
2.4
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
80%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
201465
Alexa Website Rank
365190
Alexa Website Rank
513559
Alexa Website Rank
396119
Alexa Website Rank
N/A
Employee Rating
Employee Rating
2.8
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
£24.3m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
£18.7m (FY, 2018)
Revenue (est.)
$12.8m (FY, 2019)
Revenue (est.)
$111.9m (FY, 2017)
Cost of goods
Cost of goods
£83.6m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$10m (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
(£59.3m) (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Gross profit
$2.8m (FY, 2019)
Gross profit
N/A
Net income
Net income
(£71.6m) (FY, 2018)
Net income
($40.1m) (FY, 2019)
Net income
(£2.6m) (FY, 2018)
Net income
($24.5m) (FY, 2019)
Net income
($437.1m) (FY, 2017)

Funding

Latest funding round
Latest funding round
$ 170m (7 months ago)
Latest funding round
N/A
Latest funding round
$ 9.4m (almost 7 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 490m
Total funding raised
$ 49m
Total funding raised
$ 57.3m
Total funding raised
N/A
Total funding raised
$ 310m
For sources of this data, please see the company profile

View company profiles

LogicBio Therapeutics
HQ
Lexington, US
Employees
41

LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.

View company
F-star Biotechnology
HQ
Cambridge, GB
Employees
86↓ 4% decrease

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

View company
KemPharm
HQ
Kissimmee, US
Employees
33↑ 3% increase

KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.

View company
Juno Therapeutics
HQ
Seattle, US

Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.

View company